University of Science and Technology

The 6th WLA Forum Ends with Strong Call for Global Scientific Cooperation

Retrieved on: 
Thursday, November 9, 2023

At the flagship WLA Life Science Forum, the WLA Intelligent Science Forum, and the WLA Zero Carbon Forum, the world laureates and scholars discussed about the transformation in the fields for applicable solutions to address pressing global issues.

Key Points: 
  • At the flagship WLA Life Science Forum, the WLA Intelligent Science Forum, and the WLA Zero Carbon Forum, the world laureates and scholars discussed about the transformation in the fields for applicable solutions to address pressing global issues.
  • Some really touching and inspiring moments happened during the attention-drawing WLA SHE Forum, which were encouraging for more females to bravely pursuing the scientific ambitions.
  • and Angela Chan Distinguished Chair in Energy and Professor of Chemistry at UC Berkeley emphasized the importance of scientific cooperation to address the global issues.
  • The 7th WLA Forum will take place in 2024 and the nomination for the 2024 WLA Prize will kick off soon.

The 6th WLA Forum Ends with Strong Call for Global Scientific Cooperation

Retrieved on: 
Thursday, November 9, 2023

At the flagship WLA Life Science Forum, the WLA Intelligent Science Forum, and the WLA Zero Carbon Forum, the world laureates and scholars discussed about the transformation in the fields for applicable solutions to address pressing global issues.

Key Points: 
  • At the flagship WLA Life Science Forum, the WLA Intelligent Science Forum, and the WLA Zero Carbon Forum, the world laureates and scholars discussed about the transformation in the fields for applicable solutions to address pressing global issues.
  • Some really touching and inspiring moments happened during the attention-drawing WLA SHE Forum, which were encouraging for more females to bravely pursuing the scientific ambitions.
  • and Angela Chan Distinguished Chair in Energy and Professor of Chemistry at UC Berkeley emphasized the importance of scientific cooperation to address the global issues.
  • The 7th WLA Forum will take place in 2024 and the nomination for the 2024 WLA Prize will kick off soon.

AI Diagnostic Platform Company Noul, unveils the result of Malaria study in Ethiopia and Ghana

Retrieved on: 
Monday, October 23, 2023

In the study, the scientists compared the sensitivity and specificity of the qPCR with those of miLab™, field microscopy, and Rapid Diagnostic Test (RDT) respectively.

Key Points: 
  • In the study, the scientists compared the sensitivity and specificity of the qPCR with those of miLab™, field microscopy, and Rapid Diagnostic Test (RDT) respectively.
  • Diagnosis of P. falciparum infections included cases with hrp2/hrp3 gene deletion with renders parasites 'invisible' to common rapid diagnostic tests.
  • Also, the diagnostic results of miLab™ in P. falciparum infected patients with hrp2/hrp3 gene deletion have been released.
  • This new study in Ethiopia and Ghana confirmed the clinical performance of miLab™ as a reliable new tool in the diagnosis of P. falciparum and P. vivax malaria.

Ricardo Helps City of Warsaw to Introduce its First Ever Low Emission Zone

Retrieved on: 
Tuesday, March 28, 2023

In 2018, 36 out of 50 most polluted cities in the European Union (EU) were in Poland.

Key Points: 
  • In 2018, 36 out of 50 most polluted cities in the European Union (EU) were in Poland.
  • This is driven the desire by the city to introduce an ambitious Low Emission Zone in the city by 2024, but doing so in a way that does not disproportionately impact groups of individuals or businesses.
  • The Clean Air Fund is supporting the city with these ambitions through its Breathe Warsaw programme.
  • Elsewhere in the UK, London has introduced its Ultra Low Emission Zone (ULEZ), while Bath, Birmingham and Bradford have active Clean Air Zones (CAZ).

Sendero Resources Corp. Announces Private Placement Financing for up to $4,000,000, Contemplated Listing on TSX Venture Exchange and the Entering into of a Definitive Agreement for Business Combination with 1319732 B.C. Ltd.

Retrieved on: 
Friday, March 3, 2023

Concurrently with the completion of the Transaction, the Resulting Issuer will seek to list its common shares for trading on the TSX Venture Exchange (the "Exchange").

Key Points: 
  • Concurrently with the completion of the Transaction, the Resulting Issuer will seek to list its common shares for trading on the TSX Venture Exchange (the "Exchange").
  • Sendero will look to take advantage of its experience and operational knowledge to advance high priority drilling targets.
  • Each Unit is comprised of one Sendero common share and one-half of one Sendero common share purchase warrant (each whole warrant, a "Warrant").
  • Following the Adjustment and as part of the Transaction, Sendero shareholders will receive one Resulting Issuer common share for each Sendero common share.

Cardior Appoints Axel-Sven Malkomes as Chief Financial Officer

Retrieved on: 
Thursday, November 3, 2022

Cardior Pharmaceuticals , a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Axel-Sven Malkomes as Chief Financial Officer (CFO).

Key Points: 
  • Cardior Pharmaceuticals , a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Axel-Sven Malkomes as Chief Financial Officer (CFO).
  • Mr. Malkomes brings to Cardior nearly 30 years of life science industry experience from executive roles, investment banking, healthcare investing, and corporate development positions.
  • His decades of experience in the industry, with a strong track record across the financial side of biotech, will be an important addition to our team.
  • Mr. Malkomes started his career in investment banking at a range of banking institutions, namely Dresdner Bank, Sal.

Moonshot Commons Raised Seed Round from HashKey Capital to “break geo-barriers” for the next Gen-Z founders in Web3

Retrieved on: 
Sunday, October 30, 2022

Founded by Wharton, Vassar engineering students, Moonshot Commons has recently raised a seed round to break geo-barriers for the next Gen-Z founders in Web3.

Key Points: 
  • Founded by Wharton, Vassar engineering students, Moonshot Commons has recently raised a seed round to break geo-barriers for the next Gen-Z founders in Web3.
  • More than 10 top-tier investors and funds participated in this round, including HashKey Capital , Hash Global , Mask Network , IoTex , ChainIDE , Paeonia Ventures , RSS3 ; in addition to the founders of IOSG , ODaily , and more.
  • With its new funding round, Moonshot Commons continues to invest in its global community by curating high quality, vetted events: Mafia Mastermind Sessions (past speakers include founders of StepN, EthSign, DODO, Mask Network, RSS3, etc.
  • Moonshot also plans on investing in technologies for its graduated founders to support them in recruiting, fundraising, and more.

Second Annual RARE Health Equity Summit Addresses Gaps in Access, Shares Approaches to Build Inclusiveness in Underserved Communities

Retrieved on: 
Wednesday, October 5, 2022

Global Genes , a leading rare disease advocacy organization, will hold its second annual RARE Health Equity Summit in partnership with the Rare Disease Diversity Coalition (RDDC).

Key Points: 
  • Global Genes , a leading rare disease advocacy organization, will hold its second annual RARE Health Equity Summit in partnership with the Rare Disease Diversity Coalition (RDDC).
  • The event includes speakers from the FDA, community and patient organizations, academia and industry and will discuss approaches to address racial, ethnic, gender, socioeconomic and other disparities affecting rare disease communities.
  • The takeaways from last years inaugural Health Equity Summit highlighted the work that we must do as a community to break down barriers.
  • Black Womens Health Imperative (BWHI) launched the Rare Disease Diversity Coalition (RDDC) to address the extraordinary challenges faced by rare disease patients of color.

aTyr Pharma Presents Preclinical Research Characterizing Effects of ATYR2810 in Highly Aggressive Tumor Subtypes at the 2022 AACR Annual Meeting

Retrieved on: 
Monday, April 11, 2022

The poster and corresponding abstract are available for browsing on the AACR website through July 13, 2022.

Key Points: 
  • The poster and corresponding abstract are available for browsing on the AACR website through July 13, 2022.
  • Furthermore, ATYR2810 monotherapy inhibited spontaneous lung metastasis in an experimental model of TNBC, demonstrating the potential therapeutic effects of blocking the NRP2/VEGF signaling axis on preventing tumor persistence.
  • These findings suggests that ATYR2810 may serve as a novel therapeutic agent for the treatment of advanced and metastatic cancers.
  • aTyr Pharma, University of Massachusetts Chan Medical School, Pangu BioPharma, IAS HKUST - Scripps R&D, Hong Kong University of Science and Technology.

King Abdullah University of Science and Technology taps Canonical for cloud computing overhaul

Retrieved on: 
Tuesday, June 8, 2021

THUWAL, Saudi Arabia, June 08, 2021 (GLOBE NEWSWIRE) -- Canonical, the publisher of Ubuntu , announced today that it is working with King Abdullah University of Science and Technology (KAUST), a postgraduate university in Thuwal, Saudi Arabia, on a major upgrade of its cloud computing infrastructure.

Key Points: 
  • THUWAL, Saudi Arabia, June 08, 2021 (GLOBE NEWSWIRE) -- Canonical, the publisher of Ubuntu , announced today that it is working with King Abdullah University of Science and Technology (KAUST), a postgraduate university in Thuwal, Saudi Arabia, on a major upgrade of its cloud computing infrastructure.
  • Since 2015, the university had been operating a homegrown OpenStack private cloud in which researchers provisioned computing resources on demand.
  • Were delighted to be working with King Abdullah University of Science and Technology, said Nicholas Dimotakis, VP of Field Engineering, Canonical.
  • For additional information, visit: www.Kaust.edu.sa
    Canonical is the company behind Ubuntu, the leading OS for container, cloud, and hyperscale computing.